Trials / Completed
CompletedNCT00307060
MK0954A-264 Filter Study (0954A-264)(COMPLETED)
A Randomized, Double-Blind, Parallel-Filter Study to Evaluate the Antihypertensive Efficacy and Safety of Losartan-HCTZ Combination as Compared to Losartan Monotherapy in Patients With Essential Hypertension
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 274 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To compare the blood pressure lowering efficacy, safety and tolerability of a combination drug to a single drug taken once daily in patients with uncontrolled blood pressure following a 4-week filter on the single therapy product.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MK0954A, hydrochlorothiazide (+) losartan potassium / Duration of Treatment: 6 weeks | |
| DRUG | losartan / Duration of Treatment: 6 weeks |
Timeline
- Start date
- 2004-12-01
- Primary completion
- 2005-06-01
- Completion
- 2005-06-02
- First posted
- 2006-03-27
- Last updated
- 2024-08-15
Source: ClinicalTrials.gov record NCT00307060. Inclusion in this directory is not an endorsement.